Previously treated cases tested for RR-/MDR-TB (%) in Philippines

Philippines: Previously treated cases tested for RR-/MDR-TB was 76.0% in 2024. ◆ Volatile

Latest (2024)
76.0%
Change on year
down 16.5%
World rank
120th
of 180 countries
All-time high
97.0%
in 2022
All-time low
0.4%
in 2009
Years of data
20
2005–2024

Previously treated cases tested for RR-/MDR-TB in Philippines, 2005–2024

0204060801002005201420242005: 3.52006: 8.42007: 6.42008: 152009: 0.382010: 2.72011: 172012: 122013: 702014: 672015: 452016: 672017: 832018: 242019: 892020: 952021: 932022: 972023: 912024: 76

Source: World Health Organization, Global Health Observatory.

Analysis

In 2024, previously treated cases tested for rr-/mdr-tb in Philippines stood at 76.0%.

Compared with earlier readings it is down 16.5% on the previous year and up 13.4% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Philippines peaked at 97.0% in 2022 and was at its lowest, 0.4%, in 2009.

Philippines ranks 120th of 180 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in Philippines, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Philippines, 2005 to 2024.
Year Value Change
2005 3.5% —
2006 8.4% +140.0%
2007 6.4% -23.8%
2008 15.0% +134.4%
2009 0.4% -97.5%
2010 2.7% +610.5%
2011 17.0% +529.6%
2012 12.0% -29.4%
2013 70.0% +483.3%
2014 67.0% -4.3%
2015 45.0% -32.8%
2016 67.0% +48.9%
2017 83.0% +23.9%
2018 24.0% -71.1%
2019 89.0% +270.8%
2020 95.0% +6.7%
2021 93.0% -2.1%
2022 97.0% +4.3%
2023 91.0% -6.2%
2024 76.0% -16.5%

Philippines compared with similar countries

  • Philippines's 76.0% is below the median for upper middle income countries, which is 92.0%, 83% of the median. (52 countries reporting)
  • Philippines's 76.0% is below the median for East Asia & Pacific, which is 85.0%, 89% of the median. (28 countries reporting)

Biggest year-on-year movements

Years where Previously treated cases tested for RR-/MDR-TB in Philippines changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2010 +610.5% 0.4% 2.7%
2011 +529.6% 2.7% 17.0%
2013 +483.3% 12.0% 70.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 6.7% 0.4% 15.0% 5
2010s 47.7% 2.7% 89.0% 10
2020s 90.4% 76.0% 97.0% 5

Countries ranked near Philippines

  1. 117 Ethiopia 78.0% compare
  2. 118 Slovakia 77.0% compare
  3. 118 South Africa 77.0% compare
  4. 120 Honduras 76.0% compare
  5. 120 Australia 76.0% compare
  6. 123 Colombia 75.0% compare
  7. 123 Paraguay 75.0% compare
  8. 123 Netherlands 75.0% compare
  9. 123 Pakistan 75.0% compare

See the full ranking of 193 places →

More health data for Philippines

All data for Philippines →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Philippines?
Previously treated cases tested for rr-/mdr-tb in Philippines was 76.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Philippines?
The highest recorded value was 97.0% in 2022.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Philippines?
The lowest recorded value was 0.4% in 2009.
How does Philippines rank for previously treated cases tested for rr-/mdr-tb?
Philippines ranks 120th out of 180 countries with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Philippines?
Over the last ten years it is up 13.4%. The long-run trend across the full record is volatile.
Where does this Philippines data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Philippines. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 October 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/philippines/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/philippines/">Previously treated cases tested for RR-/MDR-TB in Philippines</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed